One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.
Jain
A B
AB
Pittsburgh Transplant Institute, University of Pittsburgh Health Science Center, Pennsylvania.
Fung
J J
JJ
Todo
S
S
Reyes
J
J
Selby
R
R
Irish
W
W
Doyle
H
H
Abu-Elmagd
K
K
Casavilla
A
A
Nour
B
B
D000328:Adult; D000367:Age Factors; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001806:Blood Urea Nitrogen; D002423:Cause of Death; D002648:Child; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D005723:gamma-Glutamyltransferase / Q000097:blood
D003404:Creatinine; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D016559:Tacrolimus